Search results for

The governor has insisted that his personal and government accounts were searched by investigators, but new court documents indicate that a personal account he shared with his wife was never searched.

When people form relationships with artificial intelligence, that could help to get work done. But a problem arises when those relationships start to replace human connections.

For months, Colleen Hoover and Emily Henry have occupied multiple spots on the New York Times paperback trade fiction bestsellers list. The success of these romance writers has been aided by Gen Z.

The search giant bought Nest, the home automation startup with smart thermostats and smart smoke detectors that are found in homes around the world. It signals a tipping point for "the Internet of things."

One of the top sources of added sugar in kids' diets is in their breakfast bowls. A new study shows that advertising drives sales of high-sugar cereals when it's aimed directly at kids under 12.

The FAA changes its tune regarding instruments on planes, the passing of "conduction" innovator Butch Morris, the stats on coughing at concerts and what the New Jersey Symphony board wasn't told about Richard Dare. Plus: violinist vs. composer and a music retailer's staff retaliates on Twitter.

Big names in business, entertainment and philanthropy pitched in to help buy a Utah ski mountain for a reported $40 million. They want to turn it into the next cool hub for culture and new ideas. "We look to build the coolest little mountain town in the world," says one of the buyers.

NPR's Leila Fadel speaks with Matt Belloni of Puck News about Netflix's acquisition of Warner Bros. and the potential challenges ahead.

Facebook founder Mark Zuckerberg is answering to dozens of senators Tuesday, after it was reported that some 87 million Facebook users' data was harvested by Cambridge Analytica. The testimony comes one week after the extent of the breach was revealed, but the company is facing questions beyond the data breach.

Most of the millions in the U.S. who are infected with hepatitis C can't afford the cure. Some say the U.S. could save money and cure more people if it bought the drugmaker Gilead Sciences Inc.